Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
In dual-agonist and triple-agonist research, it may contribute to a broader incretin response than GLP-1 alone
The appetite-suppressing effects are highly consistent, making it incredibly easy to stick to a calorie-conscious diet
1 Most events were mild to moderate and resolved as participants continued treatment
It has no established GABAergic activity, no demonstrated receptor, no reliable acute sedative effect, and no dose at which sedation predictably occurs
Research Findings Published peer-reviewed laboratory literature characterizes Ipamorelin as a selective GHS-R1a agonist that produces pulsatile GH release in rodent and swine in-vivo models without measurable elevation of stress-hormone or gonadotropin axes at preclinical doses
It assists in controlling blood sugar levels by mimicking the body's natural GLP-1 hormone
